thalidomide has been researched along with cyclosporine in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (18.92) | 18.2507 |
| 2000's | 24 (32.43) | 29.6817 |
| 2010's | 31 (41.89) | 24.3611 |
| 2020's | 5 (6.76) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bahmer, FA | 1 |
| Ekberg, H; Eriksson, T; Ostraat, O; Riesbeck, K; Schatz, H | 1 |
| Burckart, GJ; Eiras, G; Griffith, BP; Hardesty, RL; Keenan, RJ; Stuart, RS; Vogelsang, G; Zeevi, A | 1 |
| Blume, KG; Chao, N; Forman, SJ; Kashyap, A; Long, GD; Margolin, K; Molina, A; Nademanee, A; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Planas, I; Schmidt, GM; Smith, EP; Snyder, DS; Somlo, G; Spielberger, R; Stein, AS; Stepan, DE; Wilsman, K; Zwingenberger, K | 1 |
| Baumgartner, WA; Cho, PW; Gaudin, PB; Hruban, RH; Kumar, P; Stuart, RS; Uthoff, K; Vogelsang, G; Zehr, KJ | 1 |
| Deighton, J; Ewan, PW; Lachmann, PJ; Lockwood, CM; McHugh, SM; Rifkin, IR; Wilson, AB | 1 |
| Cremer, PD; Forsyth, CJ; Iland, HJ; Torzillo, P; Young, GA | 1 |
| Ekberg, H; Eriksson, T; Ostraat, O; Qi, Z; Riesbeck, K; Schatz, H | 1 |
| Ekberg, H; Gannedahl, G; Ostraat, O; Qi, Z; Tufveson, G | 1 |
| Naafs, B | 1 |
| Chuong, PH; Claude, JR; Galons, H; Huynh-Thien, D; Righenzi, S; Voisin, J; Warnet, JM; Zhu, J | 1 |
| McCune, WJ; Singer, NG | 1 |
| Fandrey, J; Jelkmann, W; Wördemann, M | 1 |
| Lisziewicz, J; Lori, F; Ravot, E | 1 |
| Bennett, GJ | 1 |
| Sakane, T; Takeno, M | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Flowers, ME; Koc, S; Leisenring, W; Martin, PJ; Nash, RA; Sanders, JE; Storb, R; Witherspoon, RP | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Lichtenstein, GR | 1 |
| Arora, M; Blazar, BR; Davies, SM; Defor, T; Enright, H; Miller, WJ; Wagner, JE; Weisdorf, DF | 1 |
| Paré, P | 1 |
| Kinsey, SE; Pratt, G | 1 |
| Atra, A; Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Meller, S; Ortin, M; Pinkerton, CR; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J | 1 |
| Alberti, LR; Chaves, DN; Pereira, WA; Petroianu, A | 1 |
| Heath, M; Raugi, GJ | 1 |
| Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M | 1 |
| Lindley, KJ; Milla, PJ; Ramsay, AD; Shah, N; Thapar, N | 1 |
| Lee, MR; Shumack, S | 1 |
| Hellström-Lindberg, E | 1 |
| Barikbin, B; Moravvej, H; Yousefi, M | 1 |
| Badgwell, C; Rosen, T | 1 |
| Alberti, LR; Carvalho, JB; de Oliveira, BH; Duarte, AB; Petroianu, A; Travolo, E | 1 |
| Jacob, SE; Kerdel, FA; Weisman, RS | 1 |
| Mitani, K | 1 |
| Guengerich, FP; Murayama, N; Okada, Y; Shimizu, M; Yamazaki, H; Yanagida, C | 1 |
| Gonda, A; Illes, A; Miltenyi, Z; Remenyik, E; Tar, I; Toth, J | 1 |
| Fang, L; Qin, T; Xiao, Z; Xu, Z; Zhang, H; Zhang, Y | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Chalmers, RJ; Reddick, CL; Singh, MN | 1 |
| Hao, YS; Liu, KQ; Qin, TJ; Xiao, ZJ; Xu, ZF; Zhang, Y | 1 |
| Bruijnen, CP; Cornelisse, PB; Cornelissen, JJ; Emmelot, M; Huisman, C; Huls, G; Janssen, JJ; Kersten, MJ; Kneppers, E; Lokhorst, HM; Meijer, E; Minnema, MC; Mutis, T; Sonneveld, P; van der Holt, B; Zweegman, S | 1 |
| Hagiwara, K; Hosokawa, A; Takahashi, K; Uezato, H; Yamaguchi, S; Yamamoto, Y | 1 |
| Marson, P; Pasero, G | 1 |
| Georgakopoulou, EA; Scully, C | 1 |
| Tohyama, K | 1 |
| Brocklehurst, P; Glenny, AM; Gorodkin, R; Pemberton, MN; Riley, P; Taylor, J; Walsh, T | 1 |
| Foley, P; Kelly, JB; Strober, BE | 1 |
| Klufas, DM; Strober, BE; Wald, JM | 1 |
| McMeniman, E; Ong, N; Pillans, P; Soyer, HP | 1 |
| Bagot, M; Barète, S; Battistella, M; Crickx, B; Deschamps, L; Flageul, B; Fraitag, S; Ingen-Housz-Oro, S; Janin, A; Kottler, D; Ortonne, N; Quéreux, G; Rybojad, M | 1 |
| Notaro, ER; Sidbury, R | 1 |
| Fang, L; Hu, N; Li, B; Pan, L; Qin, T; Qu, S; Wang, J; Xiao, Z; Xu, Z; Zhang, H; Zhang, Y | 1 |
| Aldredge, L; Armstrong, AW; Yamauchi, PS | 1 |
| Anliker, M; Boehncke, WH; Borradori, L; Conrad, C; French, LE; Gilliet, M; Häusermann, P; Itin, P; Kolios, AG; Laffitte, E; Mainetti, C; Navarini, AA; Yawalkar, N | 1 |
| Croney, S | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Kinoshita, Y; Saeki, H | 1 |
| Armstrong, AW; Enos, CW; Gottlieb, A; Langley, RG; Lebwohl, M; Merola, JF; Ryan, C; Siegel, MP; Van Voorhees, AS; Weinberg, JM; Whitlock, SM; Wu, JJ | 1 |
| Cai, JF; Chen, Y; Guan, JL; Hua, YQ; Ma, HF; Shen, Y; Zou, J | 1 |
| Lacour, JP | 1 |
| Abate, LE; Friedman, AJ; Qureshi, AA; Yosipovitch, G | 1 |
| De' Angelis, GL; Di Mario, F; Fusco, C; Gaiani, F; Leandro, G; Pisani, F; Spagnoli, C | 1 |
| Cohen, GF; Om, A; Shaath, TS; Wolfe, CM | 1 |
| Geng, H; Jia, E; Jiang, Y; Qiu, X; Wei, J; Xiao, M; Xiao, Y; Xie, J; Zhang, J; Zhang, Y; Zhong, L | 1 |
| Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Prater, EF; Rahimi, RS; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Tapper, EB; Wong, EB; Wu, JJ | 1 |
| Akiyama, M; Ando, Y; Ohshima, Y; Takama, H; Watanabe, D; Yanagishita, T | 1 |
| Beecker, J; Jacobsen, A; Langley, A; Mutter, E; Olabi, B; Pardo Pardo, J; Parker, R; Ramsay, T; Saavedra, A; Shelley, A; Stewart, F; Worley, B | 1 |
| Cheirif-Wolosky, O; Elizalde-Jiménez, IG; Romero, MTG | 1 |
25 review(s) available for thalidomide and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clofazimine; Cyclosporine; Drug Administration Schedule; Erythema Nodosum; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Peripheral Nervous System Diseases; Prednisolone; Prednisone; Thalidomide | 1996 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
New uses for old drugs in HIV infection: the role of hydroxyurea, cyclosporin and thalidomide.
Topics: Cyclosporine; HIV Infections; Humans; Hydroxyurea; Immunosuppressive Agents; Nucleic Acid Synthesis Inhibitors; Thalidomide | 1999 |
Novel approaches to Behçet's disease.
Topics: Antiviral Agents; Behcet Syndrome; Cyclosporine; Humans; Immunosuppressive Agents; Interferon-alpha; Thalidomide | 2000 |
Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Etanercept; Female; Gastrointestinal Agents; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Receptors, Tumor Necrosis Factor; Thalidomide; Treatment Outcome | 2001 |
Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mercaptopurine; Methotrexate; Rectal Fistula; Thalidomide | 2001 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Efficacy of conventional immunosuppressive drugs in IBD.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide | 2004 |
Prurigo nodularis: a review.
Topics: Administration, Topical; Antipruritics; Capsaicin; Cholecalciferol; Combined Modality Therapy; Cryotherapy; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Mast Cells; Nerve Growth Factor; Neuropeptides; Prurigo; Thalidomide; Treatment Outcome; Ultraviolet Therapy | 2005 |
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigen Presentation; Antimalarials; Chlorambucil; Contraindications; Cyclosporine; Cytokines; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Laser Therapy; Leflunomide; Male; Melatonin; Methotrexate; Models, Immunological; Pentoxifylline; Pregnancy; Pregnancy Complications; Sarcoidosis; Skin Diseases; Tetracyclines; Th1 Cells; Thalidomide | 2007 |
[Myelodysplastic syndrome].
Topics: alpha Catenin; Antineoplastic Agents; Azacitidine; Cholecalciferol; Cyclosporine; Decitabine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lenalidomide; Myelodysplastic Syndromes; Prognosis; Thalidomide; Vitamin K 2; World Health Organization | 2008 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.
Topics: Anti-Infective Agents; Calcineurin Inhibitors; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Drug Interactions; Drug Monitoring; Facial Dermatoses; Humans; Immunosuppressive Agents; Mouth Diseases; Tacrolimus; Thalidomide; Tubulin Modulators | 2015 |
[Myelodysplastic syndromes: treatment strategy up-to-date].
Topics: Antilymphocyte Serum; Azacitidine; Benzoates; Cyclosporine; Cytarabine; Deferasirox; Disease Progression; Drug Discovery; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Iron Chelating Agents; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide; Triazoles | 2014 |
Interventions for the management of oral ulcers in Behçet's disease.
Topics: Acyclovir; Adrenal Cortex Hormones; Alanine; Behcet Syndrome; Colchicine; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Interferon-alpha; Oral Ulcer; Quinolones; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Stomatitis, Aphthous; Sucralfate; Thalidomide | 2014 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
Systemic Agents for Severe Atopic Dermatitis in Children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Routes; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Thalidomide | 2015 |
Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Insurance, Health, Reimbursement; Keratolytic Agents; Medication Adherence; Methotrexate; Psoriasis; Symptom Flare Up; Thalidomide | 2016 |
A Review of the Active Treatments for Toxic Epidermal Necrolysis.
Topics: Acetylcysteine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infliximab; Plasmapheresis; Stevens-Johnson Syndrome; Thalidomide; Tumor Necrosis Factor-alpha | 2017 |
Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation.
Topics: Acitretin; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Certolizumab Pegol; Cyclosporine; Dermatologic Agents; Etanercept; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Infliximab; Psoriasis; Thalidomide; Ustekinumab | 2018 |
A systematic review of evidence-based treatments for prurigo nodularis.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antidepressive Agents; Antipruritics; Calcineurin Inhibitors; Calcitriol; Capsaicin; Cyclosporine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Prurigo; PUVA Therapy; Thalidomide | 2019 |
Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Campylobacter Infections; Celiac Disease; Child; Comorbidity; Cyclosporine; Diet, Gluten-Free; Electrophysiology; Gastrointestinal Diseases; Genetic Predisposition to Disease; Guillain-Barre Syndrome; Humans; Inflammatory Bowel Diseases; Intestinal Pseudo-Obstruction; Malnutrition; Micronutrients; Muscular Dystrophy, Oculopharyngeal; Ophthalmoplegia; Peripheral Nervous System Diseases; Quality of Life; Thalidomide | 2018 |
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
Topics: Antibodies; Asian People; Cyclosporine; Dermatomyositis; Erythema; Female; Humans; Methotrexate; Middle Aged; Prednisolone; Pruritus; Thalidomide; Treatment Outcome; Ubiquitin-Activating Enzymes | 2019 |
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Child; Cyclosporine; Etanercept; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Observational Studies as Topic; Stevens-Johnson Syndrome; Thalidomide; Tumor Necrosis Factor-alpha | 2022 |
4 trial(s) available for thalidomide and cyclosporine
| Article | Year |
|---|---|
Thalidomide as salvage therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chronic Disease; Constipation; Cyclosporine; Drug Eruptions; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Neuritis; Neutropenia; Prednisone; Remission Induction; Salvage Therapy; Survival Rate; Thalidomide; Treatment Outcome | 1995 |
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Topics: Actuarial Analysis; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Graft vs Host Disease; Humans; Hypesthesia; Neutropenia; Prednisone; Thalidomide | 2000 |
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.
Topics: Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infections; Prednisone; Prognosis; Risk Factors; Salvage Therapy; Survival Analysis; Thalidomide; Transplantation, Homologous; Treatment Outcome | 2001 |
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Eruptions; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Lymphocyte Count; Male; Melphalan; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Prospective Studies; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 2011 |
45 other study(ies) available for thalidomide and cyclosporine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Therapy of lymphocytic infiltration].
Topics: Azathioprine; Clofazimine; Cyclosporine; Dapsone; Humans; Levamisole; Lymphocytosis; Skin; Skin Diseases; Thalidomide | 1992 |
Thalidomide prolongs graft survival in rat cardiac transplants.
Topics: Animals; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Heart Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred WF; Thalidomide | 1992 |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506.
Topics: Calcimycin; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immune Tolerance; In Vitro Techniques; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Phytohemagglutinins; Tacrolimus; Thalidomide | 1991 |
Thalidomide as replacement for steroids in immunosuppression after lung transplantation.
Topics: Animals; Azathioprine; Cyclosporine; Dogs; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Pneumonia; Postoperative Complications; Prednisone; Thalidomide; Wound Healing | 1995 |
The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures.
Topics: Cells, Cultured; Cyclosporine; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Immunosuppressive Agents; Lymphocyte Activation; T-Lymphocytes, Helper-Inducer; Th1 Cells; Th2 Cells; Thalidomide | 1995 |
Thalidomide responsive chronic pulmonary GVHD.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Bronchiolitis Obliterans; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Multiple Myeloma; Thalidomide | 1996 |
Thalidomide prolonged graft survival in a rat cardiac transplant model but had no inhibitory effect on lymphocyte function in vitro.
Topics: Animals; Cyclosporine; Disease Models, Animal; Drug Synergism; Female; Graft Survival; Heart Transplantation; Humans; Interleukin-2; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Microsomes, Liver; Rabbits; Rats; Rats, Inbred BN; Rats, Inbred WF; T-Lymphocyte Subsets; Thalidomide | 1996 |
Moderate additive immunosuppressive effect of thalidomide combined with cyclosporin A in rat cardiac transplantation.
Topics: Adjuvants, Immunologic; Animals; Cyclosporine; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Inbred WF; Thalidomide | 1996 |
In vitro and in vivo immunosuppressive potential of thalidomide and its derivative, N-hydroxythalidomide, alone and in combination with cyclosporin A.
Topics: Animals; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Graft vs Host Reaction; Immunosuppressive Agents; Lymphocyte Activation; Mice; T-Lymphocytes; Thalidomide | 1997 |
Tumor necrosis factor-alpha production by human hepatoma cell lines is resistant to drugs that are inhibitory to macrophages.
Topics: Adjuvants, Immunologic; Carcinoma, Hepatocellular; Cyclosporine; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Macrophages; Pentoxifylline; Pregnanes; Taurine; Thalidomide; Thiadiazines; Tumor Necrosis Factor-alpha | 1998 |
A neuroimmune interaction in painful peripheral neuropathy.
Topics: Animals; Constriction, Pathologic; Cyclosporine; Dose-Response Relationship, Drug; Immunosuppressive Agents; Male; Myositis; Neuritis; Neuroimmunomodulation; Pain; Palliative Care; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Thalidomide; Wounds and Injuries | 2000 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Blood Transfusion; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Depletion; Male; Prednisolone; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2001 |
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Thalidomide; Transplantation, Homologous | 2003 |
Effects of thalidomide, cyclosporine, and diclofenac on skin allograft survival in rabbits.
Topics: Animals; Cyclosporine; Diclofenac; Disease Models, Animal; Graft Survival; Immunosuppressive Agents; Rabbits; Skin Transplantation; Thalidomide; Time Factors | 2004 |
Long-term outcome of intractable ulcerating enterocolitis of infancy.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Colectomy; Colitis, Ulcerative; Cyclosporine; Enterocolitis; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Steroids; Thalidomide; Time Factors; Treatment Outcome | 2005 |
Update on supportive care and new therapies: immunomodulatory drugs, growth factors and epigenetic-acting agents.
Topics: Angiogenesis Inhibitors; Antilymphocyte Serum; Antineoplastic Agents; Blood Transfusion; Cyclosporine; Granulocyte Colony-Stimulating Factor; Growth Substances; Hemoglobins; Humans; Immunosuppressive Agents; Lenalidomide; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide | 2005 |
An unusual case of adult disseminated cutaneous Langerhans cell histiocytosis.
Topics: Adult; Antigens, CD1; Biomarkers; Combined Modality Therapy; Cyclosporine; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Nail Diseases; PUVA Therapy; S100 Proteins; Skin Diseases; Thalidomide | 2006 |
Effects of immunosuppression induced by thalidomide and cyclosporine in heterotopic heart transplantation in rabbits.
Topics: Animals; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Models, Animal; Rabbits; Survival Analysis; Thalidomide; Transplantation, Heterotopic | 2007 |
Pyoderma gangrenosum--rebel without a cure?
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Mycophenolic Acid; Pyoderma Gangrenosum; Recurrence; Thalidomide; Treatment Failure | 2008 |
Drug interactions of thalidomide with midazolam and cyclosporine A: heterotropic cooperativity of human cytochrome P450 3A5.
Topics: Chromatography, High Pressure Liquid; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Kinetics; Liver; Midazolam; Thalidomide | 2009 |
Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Female; Humans; Immunomodulation; Immunosuppressive Agents; Neoplasm, Residual; Paraneoplastic Syndromes; Pemphigus; Retroperitoneal Neoplasms; Thalidomide | 2009 |
Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Thalidomide; Treatment Outcome | 2011 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Comorbidity; Cyclosporine; Dapsone; Hidradenitis Suppurativa; Humans; Infliximab; Male; Methylprednisolone; Middle Aged; Minocycline; Prednisolone; Pyoderma Gangrenosum; Thalidomide; Treatment Outcome | 2010 |
[Cyclosporine A in combination with thalidomide for the treatment of patients with myelodysplastic syndromes].
Topics: Anemia, Refractory, with Excess of Blasts; Cyclosporine; Humans; Myelodysplastic Syndromes; Thalidomide; Treatment Outcome | 2010 |
Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy.
Topics: Adrenal Cortex Hormones; Cyclosporine; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Pulmonary Embolism; Radiography; Thalidomide; Treatment Outcome; Venous Thrombosis; Warfarin | 2012 |
A short story of anti-rheumatic therapy. VIII. The immunodepressants.
Topics: Alkylating Agents; Allergy and Immunology; Antimetabolites; Antirheumatic Agents; Cyclosporine; Folic Acid Antagonists; Graft Rejection; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rheumatic Diseases; Thalidomide | 2012 |
The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
Topics: Adalimumab; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Psoriasis; Severity of Illness Index; Thalidomide; Ustekinumab; Young Adult | 2015 |
A clinical audit of high-cost and off-label drug use in dermatology.
Topics: Adalimumab; Adult; Aged; Aged, 80 and over; Cyclosporine; Dermatologic Agents; Dermatology; Female; Humans; Infliximab; Male; Medical Audit; Middle Aged; Mycophenolic Acid; Off-Label Use; Queensland; Retrospective Studies; Rituximab; Skin Diseases; Thalidomide | 2017 |
Retrospective Multicentric Study of 25 Kimura Disease Patients: Emphasis on Therapeutics and Shared Features with Cutaneous IgG4-Related Disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Angiolymphoid Hyperplasia with Eosinophilia; Cyclosporine; Dermatologic Surgical Procedures; Eosinophilia; Female; Humans; Immunoglobulin E; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Male; Middle Aged; Plasma Cells; Recurrence; Retrospective Studies; Thalidomide; Young Adult | 2015 |
[Long- term outcome of thalidomide and cyclosporine in patients with IPSS low/intermediate- 1 myelodysplastic syndromes].
Topics: Adaptor Proteins, Signal Transducing; Anemia; Blood Platelets; Blood Transfusion; Bone Marrow; China; Cyclosporine; Erythrocytes; Humans; Myelodysplastic Syndromes; Neutrophils; Peptide Hydrolases; Remission Induction; Retrospective Studies; Thalidomide; Treatment Outcome; Ubiquitin-Protein Ligases | 2015 |
Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris.
Topics: Acitretin; Biological Factors; Cyclosporine; Dermatology; Fumarates; Glucocorticoids; Humans; Immunosuppressive Agents; Psoriasis; Societies, Medical; Switzerland; Thalidomide | 2016 |
Management of patients with psoriasis.
Topics: Acitretin; Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Disease Management; Emollients; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Phototherapy; Psoriasis; Thalidomide | 2017 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.
Topics: Antirheumatic Agents; Behcet Syndrome; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Pneumonia; Thalidomide | 2017 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Ustekinumab | 2017 |
Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Crohn Disease; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Perineum; Pyoderma Gangrenosum; Thalidomide | 2019 |
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
Topics: Acitretin; Cyclosporine; Drug Monitoring; Humans; Methotrexate; Piperidines; Psoriasis; Pyrimidines; Thalidomide | 2020 |
Two cases of refractory nail psoriasis successfully treated with calcipotriol plus betamethasone dipropionate gel.
Topics: Administration, Oral; Aged; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Drug Combinations; Drug Resistance; Female; Gels; Humans; Male; Middle Aged; Nail Diseases; Ointments; Psoriasis; Severity of Illness Index; Thalidomide; Treatment Outcome | 2020 |
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycophenolic Acid; Prednisone; Thalidomide | 2022 |